Although California's governor hoped to have the cheaper insulin available by last year, it may take at least another two years.
A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...
Inc., the nonprofit drug manufacturer contracted to produce insulin for California, has not started clinical trials or applied for approval from the federal Food and Drug Administration, both of which ...
The final proposed model would have had Medicare pay less for drugs that receive accelerated approvals from the Food and Drug ...
has announced that the US Food and Drug Administration (FDA) has cleared Tidepool Loop, an automated insulin dosing app intended for the management of type 1 diabetes (T1D) in those six years old ...
The announcement that inhaled insulin will soon be available in India has understandably generated a lot of excitement and ...
Newsom’s insulin fail. A drive by California Gov. Gavin Newsom to make low-cost insulin by spending $100 million in state ...
Metabolic dysfunction-associated steatotic liver disease, or MASLD, is an umbrella term describing conditions related to a ...
A law that coaxed companies to lower the price of drugs came with ... including special food, medications and a glucose monitor. They are no longer facing the highest insulin price, but their ...
Neither clinical trials nor an application for federal approval from the Food and Drug Administration (FDA) are underway, meaning it's highly unlikely the state-manufactured insulin will be ...